Concerns have been raised in the past about the possibility of infection caused by immune suppression.
Moura and colleagues in Canada found no increase in risk of hospitalized infection in patients with ankylosing spondylitis (AS) who take disease-modifying antirheumatic (DMARDs) or anti-tumor necrosis factor (TNF-I) drugs.1 Thumb through the slides for the details of their study and the take-home points for physicians.